P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION

• A. Röth,
• M. Egyed,
• S. Ichikawa,
• Y. Ito,
• J. S. Kim,
• Z. Nagy,
• N. Obara,
• J. Panse,
• H. Schrezenmeier,
• S. Sica,
• J. Soret,
• K. Usuki,
• S.-S. Yoon,
• K. Benkali,
• M. Buri,
• P. Lundberg,
• H. Patel,
• K. Shinomiya,
• S. Sreckovic,
• J.-I. Nishimura

Affiliations

A. Röth

1 Department of Hematology and Stem Cell Transplantation, West German Cancer Centre, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

M. Egyed

2 Kaposi Mor Oktato Korhaz, Kaposvar, Hungary

S. Ichikawa

3 Tohoku University Hospital, Miyagi

Y. Ito

4 First Department of Internal Medicine, Hematology Division, Tokyo Medical University, Tokyo, Japan

J. S. Kim

5 Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea

Z. Nagy

6 Semmelweis University, Budapest, Hungary

N. Obara

7 Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

J. Panse

8 University Hospital RWTH Aachen, Aachen

H. Schrezenmeier

9 Institute of Transfusion Medicine, University Hospital Ulm, Ulm, Germany

S. Sica

10 Fondazione Policlinico Universitario A. Gemelli-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy

J. Soret

11 Centre d’Investigation Clinique, Hôpital Saint-Louis, Paris, France

K. Usuki

12 NTT Medical Center Tokyo, Tokyo, Japan

S.-S. Yoon

13 Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

K. Benkali

14 Certara, Inc., Paris, France

M. Buri

15 F. Hoffmann-La Roche, Ltd., Basel, Switzerland

P. Lundberg

15 F. Hoffmann-La Roche, Ltd., Basel, Switzerland

H. Patel

16 Genentech, Inc., South San Francisco, CA, United States of America

K. Shinomiya

17 Chugai Pharmaceutical Co., Tokyo

S. Sreckovic

15 F. Hoffmann-La Roche, Ltd., Basel, Switzerland

J.-I. Nishimura

18 Graduate School of Medicine, Osaka University, Osaka, Japan